Cumberland Pharmaceuticals (NASDAQ:CPIX) Receives New Coverage from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a report published on Friday. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Cumberland Pharmaceuticals Price Performance Shares of CPIX stock opened at $2.02 on Friday. The company has a debt-to-equity ratio of 0.36, a current ratio of […]
More Stories
Disney to Pay $10 Million to Resolve Children’s Privacy Claims
By Bill Pan Disney will pay $10 million to settle allegations that it violated a federal children’s privacy law through...
Federal Reserve Minutes Reflect Ongoing Divergence Over Interest Rates
By Andrew Moran The Federal Reserve’s December meeting proved far more fractured than the final vote suggested, underscoring the persistent...
US, Allied Forces Have Killed or Captured More Than 2 Dozen ISIS Operatives in Syria
By Jacob Burg The United States and its partner forces have captured or killed nearly 25 operatives of the ISIS...
Beijing Invokes ‘Make America Great Again’ in Rare Bid to Ease US Tensions
By Michael Zhuang From Dec. 26 to 29, Chinese state media published a rare series of editorials striking a conciliatory...
Judge Blocks White House’s Attempt to Defund Consumer Watchdog Agency
By Jack Phillips A federal judge ruled Tuesday that the White House cannot lapse its funding of the Consumer Financial...
Top 11 Hottest News Anchors in the World of All Time
News anchors have become a part of global personality. They are no longer just people who read headlines. Now, viewers...